Real-world outcomes after 36 months treatment with ranibizumab 0.5 mg in patients with visual impairment due to diabetic macular edema (BOREAL-DME)
Massin, Pascale, Creuzot-Garcher, Catherine, Kodjikian, Laurent, Girmens, Jean-François, Delcourt, Cécile, Fajnkuchen, Franck, Glacet-Bernard, Agnès, Guillausseau, Pierre-Jean, Guthux, Francoise, BJournal:
Ophthalmic Research
DOI:
10.1159/000511591
Date:
September, 2020
File:
PDF, 693 KB
2020